Ameritas Investment Partners’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.9K | Hold |
12,042
| – | – | ﹤0.01% | 2315 |
|
|
2025
Q1 | $48.3K | Hold |
12,042
| – | – | ﹤0.01% | 2121 |
|
|
2024
Q4 | $78.2K | Hold |
12,042
| – | – | ﹤0.01% | 1927 |
|
|
2024
Q3 | $66.7K | Hold |
12,042
| – | – | ﹤0.01% | 2025 |
|
|
2024
Q2 | $67.2K | Hold |
12,042
| – | – | ﹤0.01% | 1972 |
|
|
2024
Q1 | $80.8K | Hold |
12,042
| – | – | ﹤0.01% | 1870 |
|
|
2023
Q4 | $110K | Hold |
12,042
| – | – | ﹤0.01% | 1668 |
|
|
2023
Q3 | $66.5K | Buy |
12,042
+2,033
| +20% | +$11.2K | ﹤0.01% | 1927 |
|
|
2023
Q2 | $85.5K | Buy |
10,009
+1,445
| +17% | +$12.3K | ﹤0.01% | 1703 |
|
|
2023
Q1 | $78.7K | Hold |
8,564
| – | – | ﹤0.01% | 1687 |
|
|
2022
Q4 | $93.8K | Hold |
8,564
| – | – | ﹤0.01% | 1647 |
|
|
2022
Q3 | $126K | Hold |
8,564
| – | – | 0.01% | 1333 |
|
|
2022
Q2 | $91K | Buy |
8,564
+997
| +13% | +$10.6K | ﹤0.01% | 1577 |
|
|
2022
Q1 | $82K | Buy |
7,567
+6,336
| +515% | +$68.7K | ﹤0.01% | 1763 |
|
|
2021
Q4 | $20K | Hold |
1,231
| – | – | ﹤0.01% | 2640 |
|
|
2021
Q3 | $26K | Buy |
+1,231
| New | +$26K | ﹤0.01% | 2554 |
|